GRAPE • Glycemic Response of Amylopectin Containing Drinks
NCT ID: NCT03916692
Last Updated: 2022-09-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
15 participants
INTERVENTIONAL
2019-04-23
2021-08-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the study is to quantify the glycemic index of the SP energy-smart-based nutrition supplement and the SP Glucose-support formula as compared to a glucose drink. We hypothesized that both the energy-smart-based nutritional supplement and the SP Glucose-support formula will have low glycemic index.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Glycemic Responses to Nutritional Products-INQ-2526
NCT07243743
Effect of Various Processed Oat Bran in a Beverage Matrix on Glycaemic Health
NCT04930250
The Attenuating Effect of Soluble Fiber Consumption on Postprandial Glycemia in Humans
NCT05349916
The Effect of Sprouting of Wheat on Postprandial Glycemic and Satiety Responses of Wheat Bread Products
NCT05526937
Acute Effects of Juice Consumption With Biofunctional Compounds and Probiotics on Glucose Metabolism
NCT05702359
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Preliminary Testing: Medical history, weight, height, body composition via dual x-ray absorptiometry (DXA) and glycosylated hemoglobin (HbA1c) measurement.
Protocol: After a 10-hour overnight fast, subjects will complete 3 experimental visits in which they will ingest one of three beverages in a randomized order. During experimental visits subjects will either be given the following 3 experimental drinks:
* Full SP-glucose balance formula (200 kcal)
* Energy smart carbohydrate blend (50 g, 200 kcal)
* Liquid dextrose solution in the form of TRUTOL ® Glucose Tolerance Test Beverage (50 g, 200 kcal)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Standard Process - glucose balance
Standard Process - glucose balance formula (200 kcal)
Carbohydrate drink
Meal replacement drink containing 200 kcal
Energy smart Carbohydrate blend
Energy smart carbohydrate blend (50 grams, 200 kcal)
Energy smart Carbohydrate blend
Carbohydrate blend drink designed for low glycemic responses containing 200 kcal
Liquid Dextrose Control
Liquid dextrose solution in the form of TRUTOL ® Glucose Tolerance Test Beverage (50 grams, 200 kcal)
Liquid Dextrose
Liquid Dextrose drink of 200 kcal
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Carbohydrate drink
Meal replacement drink containing 200 kcal
Energy smart Carbohydrate blend
Carbohydrate blend drink designed for low glycemic responses containing 200 kcal
Liquid Dextrose
Liquid Dextrose drink of 200 kcal
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* HbA1c \> 6.5
* competitive athletes
* body weigh change \> 3kg during last month
30 Years
55 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Standard Process Inc.
INDUSTRY
Arizona State University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Stavros Kavouras, PhD
Role: PRINCIPAL_INVESTIGATOR
Arizona State University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arizona Biomedical Collaborative
Phoenix, Arizona, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FP00016578
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.